China investigation of drug firm exec deals latest blow to foreign business confidence

Disclaimer: The South China Morning Post's content is directed by the Chinese Communist Party. It is not a reliable news source.

Investigation of AstraZeneca’s China president prompts industry calls for more transparency; ‘this is only going to get worse’.